BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4395 related articles for article (PubMed ID: 26980727)

  • 1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms.
    Swerdlow SH; Campo E; Pileri SA; Harris NL; Stein H; Siebert R; Advani R; Ghielmini M; Salles GA; Zelenetz AD; Jaffe ES
    Blood; 2016 May; 127(20):2375-90. PubMed ID: 26980727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Overview of lymphoid neoplasms in the fourth edition of the WHO classification].
    Tohda S
    Rinsho Byori; 2012 Jun; 60(6):560-4. PubMed ID: 22880234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
    Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
    Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2016 revision of the WHO classification of lymphoid neoplasms].
    Tamaru JI
    Rinsho Ketsueki; 2017; 58(10):2188-2193. PubMed ID: 28978864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reticulo-endothelial tumours of the orbit.
    Nolan J
    Br J Ophthalmol; 1968 Jul; 52(7):532-9. PubMed ID: 5724440
    [No Abstract]   [Full Text] [Related]  

  • 6. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.
    Campo E; Jaffe ES; Cook JR; Quintanilla-Martinez L; Swerdlow SH; Anderson KC; Brousset P; Cerroni L; de Leval L; Dirnhofer S; Dogan A; Feldman AL; Fend F; Friedberg JW; Gaulard P; Ghia P; Horwitz SM; King RL; Salles G; San-Miguel J; Seymour JF; Treon SP; Vose JM; Zucca E; Advani R; Ansell S; Au WY; Barrionuevo C; Bergsagel L; Chan WC; Cohen JI; d'Amore F; Davies A; Falini B; Ghobrial IM; Goodlad JR; Gribben JG; Hsi ED; Kahl BS; Kim WS; Kumar S; LaCasce AS; Laurent C; Lenz G; Leonard JP; Link MP; Lopez-Guillermo A; Mateos MV; Macintyre E; Melnick AM; Morschhauser F; Nakamura S; Narbaitz M; Pavlovsky A; Pileri SA; Piris M; Pro B; Rajkumar V; Rosen ST; Sander B; Sehn L; Shipp MA; Smith SM; Staudt LM; Thieblemont C; Tousseyn T; Wilson WH; Yoshino T; Zinzani PL; Dreyling M; Scott DW; Winter JN; Zelenetz AD
    Blood; 2022 Sep; 140(11):1229-1253. PubMed ID: 35653592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the art in natural killer cell malignancies.
    Semenzato G; Marino F; Zambello R
    Int J Lab Hematol; 2012 Apr; 34(2):117-28. PubMed ID: 21895989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes of the WHO classification of lymphoid neoplasms in the context of the 2016 revision].
    Balhárek T; Marcinek J; Plank L
    Cesk Patol; 2017; 53(3):122-128. PubMed ID: 28937779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications.
    Campo E; Swerdlow SH; Harris NL; Pileri S; Stein H; Jaffe ES
    Blood; 2011 May; 117(19):5019-32. PubMed ID: 21300984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical Implications of the 2016 Revision of the World Health Organization Classification of Lymphoid and Myeloid Neoplasms and Acute Leukemia.
    Leonard JP; Martin P; Roboz GJ
    J Clin Oncol; 2017 Aug; 35(23):2708-2715. PubMed ID: 28654364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The current lymphoma classification: new concepts and practical applications triumphs and woes.
    Bakshi N; Maghfoor I
    Ann Saudi Med; 2012; 32(3):296-305. PubMed ID: 22588443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current problems in classification and diagnosis of lymphoproliferative diseases].
    Berceanu S; Gociu M
    Stud Cercet Med Interna; 1973; 14(3):197-207. PubMed ID: 4574133
    [No Abstract]   [Full Text] [Related]  

  • 13. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Histopathology; 2000 Jan; 36(1):69-86. PubMed ID: 10632755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-neoplasms. Their significance in relation to the classification system of lymphoid neoplasms.
    Collins RD
    Am J Surg Pathol; 1982 Dec; 6(8):745-54. PubMed ID: 6984812
    [No Abstract]   [Full Text] [Related]  

  • 15. The World Health Organization classification of hematological malignancies report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997.
    Harris NL; Jaffe ES; Diebold J; Flandrin G; Muller-Hermelink HK; Vardiman J; Lister TA; Bloomfield CD
    Mod Pathol; 2000 Feb; 13(2):193-207. PubMed ID: 10697278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostically relevant updates to the 2017 WHO classification of lymphoid neoplasms.
    Choi SM; O'Malley DP
    Ann Diagn Pathol; 2018 Dec; 37():67-74. PubMed ID: 30308438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Importance of cytogenetic methods of examination in the hematological clinic].
    Fleĭshman EV
    Klin Med (Mosk); 1974 Nov; 52(11):31-8. PubMed ID: 4530882
    [No Abstract]   [Full Text] [Related]  

  • 18. A practical approach to the pathology of lymphoid neoplasms: a revised European-American classification from the International Lymphoma Study Group.
    Harris NL
    Important Adv Oncol; 1995; ():111-40. PubMed ID: 7672801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphoid tissue neoplasms: lympholeukemia and (or) lymphoma].
    Morozova VT
    Klin Lab Diagn; 2002 Mar; (3):43-50. PubMed ID: 11980146
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.
    Lynch RC; Gratzinger D; Advani RH
    Curr Treat Options Oncol; 2017 Jul; 18(7):45. PubMed ID: 28670664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 220.